ERT, a leading provider of centralized ECG, eClinical technology, ePRO and other services to the biopharmaceutical, medical device and related industries, announced today its transition to a brand new facility in Philadelphia to accommodate the company's remarkable growth. With one and a half floors of office space, more than double the size of the former premises, the new facility houses the company's primary headquarters and logistics operations.
This new 58,000 square foot facility is over double the size of the previous building and also features a new designated 16,000 square foot state-of-the-art logistics operations area situated on the concourse. The logistics operations facility offers access to a secure area and private access to the loading bay, essential for the logistical aspects of sending equipment to sponsors sites. This area has also been customized to support the specific testing requirements of the ECG equipment.
With a view to enhancing the working environment and offering superior ergonomics to staff, ERT invested heavily in the design of modern premises with spacious offices and adjustable furniture and equipment to suit different needs. Staff were actively involved in the process, which resulted in developing an open-plan employee-friendly environment with designated areas of workspace. The benefits of a contented workforce helps promote internal collaboration and overall enhances productivity.
The new facility operation was driven and co-ordinated by Amy Furlong, Executive Vice President, Cardiac Safety Operations, ERT. This entire process was completed within a weekend to minimize disruption to staff and customers and ERT ECG receiving center experienced less than 24 hours down time over the weekend.
Amy Furlong comments; "Philadelphia remained the location of choice in terms of convenience for existing staff as well as for recruiting new talent. Based on the infrastructure in Philadelphia we are able to bring people from a tri-state area into city centre Philadelphia. With this new facility, we mark the beginning of a new era of innovation and growth," commented Amy Furlong. "The new offices and logistics operations area allow us to offer our staff an improved working environment and further strengthens our leading position as a provider of best-in-class technology and services for the successful execution of clinical trials."
About eResearchTechnology, Inc. (ERT)
Based in Philadelphia, PA ERT (ERT.com) is a provider of technology and services to the global biopharmaceutical and medical device industries. The company is a market leader in providing centralized core-diagnostic electrocardiographic (ECG) technology and services to evaluate cardiac safety in clinical development. The company is also a leader in providing technology and services to streamline the clinical trials process by enabling its customers to automate the collection, analysis and distribution of clinical data in all phases of clinical development.
Statements included in this release may constitute forward-looking statements within the meaning of the Private Securities Litigation Reform Act of 1995. Such statements, including, but not limited to, 2009 financial guidance, involve a number of risks and uncertainties such as the Company's ability to obtain new contracts and accurately estimate net revenues due to uncertain regulatory guidance, variability in size, scope and duration of projects, and internal issues at the sponsoring client, integration of acquisitions, competitive factors, technological development, and market demand. As a result, actual results may differ materially from any financial outlooks stated herein. Further information on potential factors that could affect the Company's financial results can be found in the Company's Reports on Form 10-K and 10-Q filed with the Securities and Exchange Commission. The Company undertakes no obligation to publicly update any forward-looking statement, whether as a result of new information, future events, or otherwise.